Latest Patent Filings News

Papyrus Australia has produced a second batch of TBS board samples, expanded pulp capacity in Adelaide and secured additional funding as it moves towards commercial supply. The progress comes with testing still incomplete and an estimated 4.87 months of funding available.

FirstWave Cloud Technology has lodged a provisional patent for an AI-driven network monitoring system that promises automated, explainable root cause diagnosis, aiming to boost its fastest-growing revenue stream.

InFocus Group Holdings has secured $450,000 in a placement to fund the commercialisation of its AI-driven Codexa sweepstakes casino platform, targeting the US market with new compliance technology and patent applications.

Nanoveu's EMASS division has been granted a US patent for a silicon accelerator that dramatically speeds up AI object detection, underpinning its next-gen ECS-DoT chip now in production at TSMC.

Anson Resources has lodged two US patent applications for a novel chemical-free technology that removes iron from lithium-rich brines, potentially cutting costs and environmental impact in its Direct Lithium Extraction process.

Singular Health Group lifted revenues over fivefold to $1.43 million in FY26, driven by US commercial rollouts of its 3DICOM platform, but posted a $6.34 million loss. The company strengthened its US foothold with FDA clearance and a controlling stake in an associate.

Actinogen Medical reported a $15.38 million loss for FY2026 while progressing its lead Alzheimer's drug Xanamem toward pivotal trial results expected this November. The company secured regulatory alignment and strengthened its cash position to fund operations through mid-2027.

IPH Limited reported a 16.9% jump in net profit to $80.4 million for FY26, driven by strong Canadian growth and operational discipline, alongside a new CEO appointment and its inaugural sustainability report.

Mount Ridley Mines has lodged a provisional patent for its SelectroTM hydrometallurgical leach technology, demonstrating superior recoveries of rare earths, scandium, and gallium compared to conventional methods. The company is advancing testwork and commercial discussions to capitalise on the innovation.

Temas Resources posted a CAD 2.63 million loss for H1 2026, driven by ramped-up exploration and RCL technology development, while securing $1.5 million in fresh funding and signing initial RCL licensing contracts.

Singular Health deepens US healthcare foothold with ongoing Triple-S contract talks, PNS licence expansion, and Miami-Dade educational rollout, supported by a solid $10.1 million cash reserve.

Biome Australia capped FY26 with record $23.9 million sales and its flagship probiotic topping Australian pharmacy charts. The company signed an onshore manufacturing deal and expanded its proprietary probiotic clinical trial internationally.